Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and sapropterin

methoxyhydroxyphenylglycol has been researched along with sapropterin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lamers, KJ; Wevers, RA1
Arnold, LA; Blanchet, PJ; Chase, TN; Hyland, K; Konitsiotis, S; Pettigrew, KD1
Kaneko, YS; Mori, K; Nagatsu, I; Nagatsu, T; Nakashima, A; Ota, A1

Reviews

1 review(s) available for methoxyhydroxyphenylglycol and sapropterin

ArticleYear
Effect of peripherally administered lipopolysaccharide (LPS) on GTP cyclohydrolase I, tetrahydrobiopterin and norepinephrine in the locus coeruleus in mice.
    Stress (Amsterdam, Netherlands), 2007, Volume: 10, Issue:2

    Topics: Animals; Biopterins; Cell Line, Tumor; GTP Cyclohydrolase; Lipopolysaccharides; Locus Coeruleus; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Tyrosine 3-Monooxygenase

2007

Other Studies

2 other study(ies) available for methoxyhydroxyphenylglycol and sapropterin

ArticleYear
Abnormalities of biogenic amines affecting the metabolism of serotonin and catecholamines.
    Multiple sclerosis (Houndmills, Basingstoke, England), 1998, Volume: 4, Issue:1

    Topics: Aromatic-L-Amino-Acid Decarboxylases; Biopterins; Catecholamines; Child; Child, Preschool; Dopa Decarboxylase; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Infant, Newborn; Metabolism, Inborn Errors; Methoxyhydroxyphenylglycol; Serotonin; Tyrosine 3-Monooxygenase

1998
Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger.
    Experimental neurology, 1998, Volume: 153, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Biopterins; Disease Models, Animal; Female; Free Radical Scavengers; Homovanillic Acid; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Motor Activity; Parkinson Disease, Secondary; Pilot Projects; Piperazines

1998